1031-107 The vascular endothelial growth factor +405 CC promotor polymorphism is associated with an impaired prognosis in patients with chronic heart failure: For the MERIT-HF study group.

Authors :: Van der Meer, Peter
De Boer, Rudolf A
White, Hazel L
Hall, Alistair S
Hillege, Hans
Van Veldhuisen, Dirk J
Source :: Journal of the American College of Cardiology (JACC). Mar2004 Supplement 1, Vol. 43, pA163-A163. 1p.
Publication Year :: 2004

Subjects :: *VASCULAR endothelial growth factors
*HEMOGLOBIN polymorphisms
*HEART failure
*HEART transplantation
*DISEASE progression
*PROGNOSIS

Full Text Access

Tools